## Background: Clinical research of prostate carcinoma could be enhanced by models that allow early and reliable prediction of outcome. in this study, the authors describe a model-building strategy and compare different models. ## Methods: The sample population was comprised of 158 patients treat
Analyzing predictive models following definitive radiotherapy for prostate carcinoma
โ Scribed by Benjamin Movsas; Alexandra L. Hanlon; Teruki Teshima; Gerald E. Hanks
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 141 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
independent clinical outcome data measuring biochemical freedom from failure (bNED control), thereby warranting further exploration.
๐ SIMILAR VOLUMES
## BACKGROUND. In most reported surgical series, prostate carcinoma patients with a Gleason score of 7 have had worse outcomes than those with other moderately differentiated cancers. Because of variations in reporting grade and grouping Gleason scores, radiation series have conflicting results.
tomy for clinically localized prostate carcinoma are found to have microscopic disease that is not organ-confined, and a significant portion of these patients will
or neoadjuvant hormonal or radiation therapy were excluded. Akaike's Information Criterion (AIC) and Schwartz Bayesian Criterion (SBC) estimates, which are com-1 Joint Center for Radiation Therapy, Harvard parative measures, were calculated for each clinical staging system. Pairwise com-Medical Scho